ABK-EGFR-1
/ Abbisko
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
Discovery and characterization of ABK-EGFR-1, a 4th generation EGFR C797S Inhibitor with excellent selectivity and brain penetration
(AACR 2026)
- "Abstract is embargoed at this time."
Late-breaking abstract • Oncology
1 to 1
Of
1
Go to page
1